<?xml version="1.0" encoding="ISO-8859-1"?>
<rss version="2.0">
    <channel>
        <title>PR.com Press Releases: Carmel Pharma., Inc. News</title>
        <description>Latest news releases from PR.com for Carmel Pharma., Inc.</description>
        <link>http://www.pr.com/press-releases</link>
        <lastBuildDate>Fri, 05 Dec 2008 11:49:32 -0500</lastBuildDate>
        <image>
            <url>http://www.pr.com/images/logo_white.jpg</url>
            <title>Press Releases from PR.com</title>
            <link>http://www.pr.com/</link>
            <width>68</width>
            <height>69</height>
            <description>PR.com provides Free Press Release Distribution, &amp; is a unique Directory of Businesses, Products, Services, &amp; Jobs - in all industries.  Find Full Company Profiles.</description>
        </image>
        <copyright>© 2008 PR Worldwide, Inc.</copyright>
        <ttl>60</ttl>
        <item>
            <title>Carmel Pharma/PhaSeal Exhibiting at Booth #1127 at ASHP MCM</title>
            <link>http://www.pr.com/press-release/120310</link>
            <description>Offerings Include Live Leakproof Integrity Test w/ Industry Thought Leaders, New Product Demos, Nintendo Wii Raffle and More. [PR.com - December 05, 2008]</description>
            <author>Carmel Pharma., Inc.</author>
            <guid isPermaLink="true">http://www.pr.com/press-release/120310</guid>
        </item>
        <item>
            <title>Carmel Pharma Introduces the Next Evolution of PhaSeal</title>
            <link>http://www.pr.com/press-release/81850</link>
            <description>Carmel Pharma, Inc. will introduce the new Injector N35 with ErgoMotion&amp;trade; at the 33rd ONS Annual Congress in Philadelphia, PA.

This new component employs the innovative and unique technology of ErgoMotion&amp;trade; - a simple turn-key motion that provides easy access during hazardous drug preparation and administration - and is exclusive to the PhaSeal&amp;reg; System. Additional benefits include the same dry, leakproof [PR.com - May 16, 2008]</description>
            <author>Carmel Pharma., Inc.</author>
            <guid isPermaLink="true">http://www.pr.com/press-release/81850</guid>
        </item>
        <item>
            <title>Survey Verifies Link Between Nurses' Illness and Occupational Exposure</title>
            <link>http://www.pr.com/press-release/64855</link>
            <description>Scientists recently released the results of the first ever national survey which assessed nurses’ extent and frequency of exposures to common health care hazards. [PR.com - December 19, 2007]</description>
            <author>Carmel Pharma., Inc.</author>
            <guid isPermaLink="true">http://www.pr.com/press-release/64855</guid>
        </item>
        <item>
            <title>Carmel Pharma Introduces the Next Evolution of PhaSeal</title>
            <link>http://www.pr.com/press-release/63292</link>
            <description>Today, Carmel Pharma, Inc. introduces the Injector Luer Lock N35 with ErgoMotion™ during the 42nd ASHP Midyear Clinical Meeting and Exhibition in Las Vegas, NV. [PR.com - December 03, 2007]</description>
            <author>Carmel Pharma., Inc.</author>
            <guid isPermaLink="true">http://www.pr.com/press-release/63292</guid>
        </item>
        <item>
            <title>Live Continuing Education for Pharmacists on the Safe Handling of Hazardous Drugs</title>
            <link>http://www.pr.com/press-release/59630</link>
            <description>Carmel Pharma, manufacturer and distributor of PhaSeal, announced that they are sponsoring a live, accredited continuing education (CE) seminar during this year’s 42nd Annual ASHP Midyear Clinical Meeting and Exhibition in Las Vegas, NV in December. [PR.com - November 09, 2007]</description>
            <author>Carmel Pharma., Inc.</author>
            <guid isPermaLink="true">http://www.pr.com/press-release/59630</guid>
        </item>
        <item>
            <title>New Research Presented by MD Anderson and University of Utah Verifies Dry Connections with PhaSeal</title>
            <link>http://www.pr.com/press-release/37882</link>
            <description>New evidence-based research was presented at ONS Congress by MD Anderson and the University of Utah which concluded only the PhaSeal System confined the drug, thus proving the prevention of drug exposure from preparation through administration of hazardous drugs. [PR.com - May 05, 2007]</description>
            <author>Carmel Pharma., Inc.</author>
            <guid isPermaLink="true">http://www.pr.com/press-release/37882</guid>
        </item>
        <item>
            <title>Carmel Pharma, Inc. Launches New PhaSeal Preparation Component</title>
            <link>http://www.pr.com/press-release/37581</link>
            <description>Carmel Pharma, Inc. launches their new Protector 28 (P28).  This preparation component is the latest advancement of the PhaSeal System and is available now. [PR.com - May 03, 2007]</description>
            <author>Carmel Pharma., Inc.</author>
            <guid isPermaLink="true">http://www.pr.com/press-release/37581</guid>
        </item>
        <item>
            <title>Carmel Pharma Offers New Continuing Education Program</title>
            <link>http://www.pr.com/press-release/36776</link>
            <description>Carmel Pharma, manufacturers and distributors of PhaSeal, announced today that they are now offering an accredited continuing education (CE) program developed by STAT Educational Services, an accredited provider of continuing education for various healthcare professionals. [PR.com - April 25, 2007]</description>
            <author>Carmel Pharma., Inc.</author>
            <guid isPermaLink="true">http://www.pr.com/press-release/36776</guid>
        </item>
        <item>
            <title>New Evidence-based Research will be Unveiled During 'Ask the Experts’ at ONS Congress in April</title>
            <link>http://www.pr.com/press-release/34747</link>
            <description>New evidence-based research for determining adherence to the NIOSH definition of a closed-system will be unveiled during &amp;lsquo;Ask the Experts&amp;rsquo; at the ONS Congress on Wednesday, April 25 in Las Vegas, NV.

&amp;lsquo;Ask the Experts&amp;rsquo; will be held from 1pm-2pm on Wednesday, April 25 in the Carmel Pharma, Inc. booth #823. This is an exclusive opportunity to interact with clinical leaders in the safe handling arena, [PR.com - April 04, 2007]</description>
            <author>Carmel Pharma., Inc.</author>
            <guid isPermaLink="true">http://www.pr.com/press-release/34747</guid>
        </item>
    </channel>
</rss>
